Dorothy J. Margolskee
Private Equity Investor bij Foresite Capital Management LLC
Oorsprong van het eerstegraads netwerk van Dorothy J. Margolskee
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Foresite Capital Management LLC
 Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management LLC (Foresite Capital) is a private equity firm founded in 2010 by James Tananbaum. The firm is headquartered in San Francisco.
49
| Private Company | Investment Managers | 49 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Dorothy J. Margolskee via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Foresite Labs LLC | Founder Chief Operating Officer Chief Executive Officer Private Equity Investor Private Equity Investor | ||
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Pennsylvania | College/University | Doctorate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a precision medicines company called Esker that aims to provide personalized treatments for people with autoimmune diseases. The company is based in San Francisco, CA. Esker uses a precision analytics platform, powered by foresite labs, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology to create medicines that change the lives of people with autoimmune disease. The company was founded by June H Lee. Martin Babler has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Founder | |
| KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Private Equity Investor | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
Foresite Life Sciences Corp.
 Foresite Life Sciences Corp. Financial ConglomeratesFinance Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA. | Financial Conglomerates | Chief Executive Officer Director of Finance/CFO Director/Board Member | |
| QUANTUM-SI INCORPORATED | Packaged Software | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Founder | |
| Yale University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| BLACKROCK, INC. | Investment Managers | Corporate Officer/Principal Private Equity Analyst | |
| University of California | College/University | Undergraduate Degree Undergraduate Degree | |
| PARDES BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Section 32 LLC
 Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | Investment Managers | Consultant / Advisor Public Communications Contact | |
| 10X GENOMICS, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
General Atlantic LLC
 General Atlantic LLC Investment ManagersFinance General Atlantic LLC (General Atlantic) is a private equity firm founded in 1980 by Charles F. Feeney. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Xinthera, Inc.
 Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline. The company is based in San Diego, CA. XinThera is backed by a group of international investors including Foresite Capital, OrbiMed Advisors, LLC, and TTM Capital. XinThera's lead programs focus on well-validated targets with a mission to rapidly create and advance fast-follower programs with potential in areas of high-unmet need. XinThera was founded by Qing Dong, Stephen W. Kaldor, and Gene Hung. The CEO is Christopher C. LeMasters. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Stanford University | College/University | Graduate Degree Graduate Degree | |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Lighthouse Capital Partners, Inc.
 Lighthouse Capital Partners, Inc. Investment ManagersFinance Lighthouse Capital Partners, Inc. (Lighthouse Capital Partners) is a venture capital firm founded in 1994 by Richard Stubblefield and Gwill York. The firm headquartered in Menlo Park, California. | Investment Managers | Comptroller/Controller/Auditor Director of Finance/CFO | |
| University of Denver | College/University | Undergraduate Degree Graduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Masters Business Admin Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| YELP INC. | Internet Software/Services | Human Resources Officer | |
| SANDOZ GROUP AG | Pharmaceuticals: Major | Director/Board Member | |
| University of California San Diego | College/University | Undergraduate Degree | |
| Boston University | College/University | Undergraduate Degree | |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Immpact Bio USA, Inc.
 Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA. | Biotechnology | Director/Board Member | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Private Equity Investor | |
| Boston University School of Medicine | College/University | Doctorate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree | |
| Bayer Pharmaceuticals Corp. | Private Equity Investor | ||
Fog Pharmaceuticals, Inc.
 Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree | |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer |
Statistieken
Internationaal
| Verenigde Staten | 48 |
| Zwitserland | 3 |
| Israël | 2 |
Sectoraal
| Health Technology | 21 |
| Consumer Services | 16 |
| Finance | 9 |
| Technology Services | 4 |
| Commercial Services | 3 |
Operationeel
| Director/Board Member | 95 |
| Corporate Officer/Principal | 55 |
| Private Equity Investor | 32 |
| Undergraduate Degree | 32 |
| Founder | 19 |
Sterkste connecties
| Insiders | |
|---|---|
| James Tananbaum | 60 |
| Brett Zbar | 23 |
| Robert Gunderson | 17 |
| Mathai Mammen | 16 |
| Vikram Bajaj | 14 |
| Matthew Buten | 13 |
| Christine Aylward | 11 |
| Dennis Ryan | 11 |
| David Weinreich | 9 |
| Matthew Dyer | 9 |
| Elizabeth Canis | 8 |
| Fred Fiedorek | 8 |
| Mike Ulyatt | 6 |
| Michael Rome | 6 |
| Jonathan Robbins | 6 |
- Beurs
- Insiders
- Dorothy J. Margolskee
- Bedrijfsconnecties
